We are developing molecular tests designed to improve the diagnostic accuracy of cytology samples, thereby helping to increase the utility of these minimally invasive procedures as an alternative to surgical biopsy. Our Goal: Enable Doctors to Make More Informed Treatment Decisions Our Focus: Molecular Cytology
Company Growth (employees)
Type
Public
HQ
South San Francisco, US
Founded
2008
Size (employees)
216 (est)+13%
Veracyte was founded in 2008 and is headquartered in South San Francisco, US

Key People at Veracyte

Bonnie Anderson

Bonnie Anderson

Co-Founder & CEO
Shelly D. Guyer

Shelly D. Guyer

CFO
Richard Lanman

Richard Lanman

Chief Medical Officer
Giulia C. Kennedy

Giulia C. Kennedy

Chief Scientific Officer
Chris Hall

Chris Hall

Chief Commercial Officer
Robert Monroe

Robert Monroe

VP, Laboratory Operations & Medical Director

Veracyte Office Locations

Veracyte has offices in South San Francisco, Austin
South San Francisco, US
Austin, US

Veracyte Metrics

Veracyte Summary

Market capitalization

$308.5 m

Closing share price

$9.2
Veracyte's current market capitalization is $308.5 m.

Veracyte Financials

Veracyte's revenue is $65.1 m in FY, 2016 which is a 31.5% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$21.9 m$38.2 m$49.5 m$65.1 m

Revenue growth, %

74.5%29.6%31.5%

Gross profit

$9.3 m$21.6 m$28 m

Operating expense total

$45.1 m$67.2 m$83 m

EBIT

($23.2 m)($29 m)($33.5 m)

Net Income

($25.6 m)($29.4 m)($33.7 m)($31.4 m)

Operating cash flow

$57.2 m($36.2 m)$4.1 m

Veracyte Market Value History

Veracyte Online Presence

Veracyte Company Life

You may also be interested in